Brief: Eledon Pharmaceuticals Reports First Quarter 2023 Operating And Financial Results
11/05/2023 21:43
May 11 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O :
* ELEDON PHARMACEUTICALS REPORTS FIRST QUARTER 2023
OPERATING AND
FINANCIAL RESULTS
* ELEDON PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.75
Source text for Eikon: ID:nGNX3WVkvz
Further company coverage: ELDN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial